扎克伯格向47位疾病研究人员捐款5000万美元

2017-02-09 佚名 新浪科技

Facebook创始人马克·扎克伯格(Mark Zukerberg)与妻子普莉希拉·陈(Priscilla Chan)共同创立的非营利医疗研究机构陈·扎克伯格生物中心(Chan Zuckerberg Biohub)今日宣布,将向疾病研究人员捐资5000万美元。 陈·扎克伯格生物中心是扎克伯格夫妇投入6亿美元建立的非营利性医疗研究机构,成员主要来自加州大学旧金山分校、斯坦福大学和加

扎克伯格计划资助近50名科学家 主要研究疟疾传播

Facebook创始人马克·扎克伯格(Mark Zukerberg)与妻子普莉希拉·陈(Priscilla Chan)共同创立的非营利医疗研究机构陈·扎克伯格生物中心(Chan Zuckerberg Biohub)今日宣布,将向疾病研究人员捐资5000万美元。

陈·扎克伯格生物中心是扎克伯格夫妇投入6亿美元建立的非营利性医疗研究机构,成员主要来自加州大学旧金山分校、斯坦福大学和加州大学伯克利分校的工程师和研究人员,其使命是攻克世界上的各种疾病。

Chan Zuckerberg Biohub将与三所大学进行合作:加州大学伯克利分校(Berkley)、中佛罗里达大学(UCF)和斯坦福大学。“与我们合作的这三所大学担负了Biohub最核心的工作。”该组织称,“我们的科学研究人员均来自于这些杰出的研究机构,它们的师资力量将成为Biohub日常业务的重要组成部分。”随着Biohub组织不断发展壮大,它还将会与其他研究机构建立合作关系。

“扎克伯格和普莉希拉是热心的科学爱好者。”Biohub组织的联合主席、加州大学旧金山分校(UCSF)教授约瑟夫·德里西(Joseph DeRisi)说,“他们热衷于学习新的事物,了解最前沿的科学研究成果。”

此次,陈·扎克伯格生物中心在700份申请表中挑选出第一批47位研究人员,在未来5年内,这些研究人员每人最高可获得150万美元的资金支持,以完成其项目研究。

在符合 “治愈、预防和控制所有疾病”这一目标的前提下,研究人员的可选研究领域非常广泛,如器官打印和细胞聚集等。陈·扎克伯格生物中心的目标非常远大。许多研究机构只专注于研究一种疾病,而陈·扎克伯格生物中心恰恰相反,它关注所有疾病。

扎克伯格夫妇2015年宣布,将捐出99%的股份给慈善基金会,价值约450亿美元。去年,二人表示将投入30多亿美元帮助科学家及工程师研发全新的工具和技术,争取在2100年前治愈、控制或根除所有疾病。

去年11月,LinkedIn联合创始人里德·霍夫曼(Reid Hoffman)与其妻子宣布向陈·扎克伯格生物中心捐款2000万美元。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2070402, encodeId=415f20e040278, content=<a href='/topic/show?id=f30de0713e1' target=_blank style='color:#2F92EE;'>#疾病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70713, encryptionId=f30de0713e1, topicName=疾病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=010d202, createdName=amy0550, createdTime=Mon Nov 13 02:35:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907466, encodeId=c724190e466c1, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Thu Oct 12 17:35:00 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=176113, encodeId=2cd61e611342, content=榜样的力量, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOWcPEsEP4FrvDcicue5V6rMkmXmY73KjYP59vQrEdjU89iaN4ZkOhsItlHkmGTjhV3b5S3zOQA4E0/0, createdBy=cc261682151, createdName=卡圣, createdTime=Tue Feb 14 12:47:47 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175375, encodeId=9f341e5375be, content=每人一百万美元,我的天啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/30/dd6bade062cb598667f9f577194196c4.jpg, createdBy=422e1687020, createdName=Dr.jerry, createdTime=Fri Feb 10 12:18:02 CST 2017, time=2017-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175241, encodeId=804b1e52415b, content=最有爱的人。, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee471989203, createdName=墨尔, createdTime=Thu Feb 09 23:08:24 CST 2017, time=2017-02-09, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2070402, encodeId=415f20e040278, content=<a href='/topic/show?id=f30de0713e1' target=_blank style='color:#2F92EE;'>#疾病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70713, encryptionId=f30de0713e1, topicName=疾病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=010d202, createdName=amy0550, createdTime=Mon Nov 13 02:35:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907466, encodeId=c724190e466c1, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Thu Oct 12 17:35:00 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=176113, encodeId=2cd61e611342, content=榜样的力量, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOWcPEsEP4FrvDcicue5V6rMkmXmY73KjYP59vQrEdjU89iaN4ZkOhsItlHkmGTjhV3b5S3zOQA4E0/0, createdBy=cc261682151, createdName=卡圣, createdTime=Tue Feb 14 12:47:47 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175375, encodeId=9f341e5375be, content=每人一百万美元,我的天啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/30/dd6bade062cb598667f9f577194196c4.jpg, createdBy=422e1687020, createdName=Dr.jerry, createdTime=Fri Feb 10 12:18:02 CST 2017, time=2017-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175241, encodeId=804b1e52415b, content=最有爱的人。, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee471989203, createdName=墨尔, createdTime=Thu Feb 09 23:08:24 CST 2017, time=2017-02-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2070402, encodeId=415f20e040278, content=<a href='/topic/show?id=f30de0713e1' target=_blank style='color:#2F92EE;'>#疾病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70713, encryptionId=f30de0713e1, topicName=疾病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=010d202, createdName=amy0550, createdTime=Mon Nov 13 02:35:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907466, encodeId=c724190e466c1, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Thu Oct 12 17:35:00 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=176113, encodeId=2cd61e611342, content=榜样的力量, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOWcPEsEP4FrvDcicue5V6rMkmXmY73KjYP59vQrEdjU89iaN4ZkOhsItlHkmGTjhV3b5S3zOQA4E0/0, createdBy=cc261682151, createdName=卡圣, createdTime=Tue Feb 14 12:47:47 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175375, encodeId=9f341e5375be, content=每人一百万美元,我的天啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/30/dd6bade062cb598667f9f577194196c4.jpg, createdBy=422e1687020, createdName=Dr.jerry, createdTime=Fri Feb 10 12:18:02 CST 2017, time=2017-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175241, encodeId=804b1e52415b, content=最有爱的人。, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee471989203, createdName=墨尔, createdTime=Thu Feb 09 23:08:24 CST 2017, time=2017-02-09, status=1, ipAttribution=)]
    2017-02-14 卡圣

    榜样的力量

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2070402, encodeId=415f20e040278, content=<a href='/topic/show?id=f30de0713e1' target=_blank style='color:#2F92EE;'>#疾病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70713, encryptionId=f30de0713e1, topicName=疾病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=010d202, createdName=amy0550, createdTime=Mon Nov 13 02:35:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907466, encodeId=c724190e466c1, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Thu Oct 12 17:35:00 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=176113, encodeId=2cd61e611342, content=榜样的力量, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOWcPEsEP4FrvDcicue5V6rMkmXmY73KjYP59vQrEdjU89iaN4ZkOhsItlHkmGTjhV3b5S3zOQA4E0/0, createdBy=cc261682151, createdName=卡圣, createdTime=Tue Feb 14 12:47:47 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175375, encodeId=9f341e5375be, content=每人一百万美元,我的天啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/30/dd6bade062cb598667f9f577194196c4.jpg, createdBy=422e1687020, createdName=Dr.jerry, createdTime=Fri Feb 10 12:18:02 CST 2017, time=2017-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175241, encodeId=804b1e52415b, content=最有爱的人。, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee471989203, createdName=墨尔, createdTime=Thu Feb 09 23:08:24 CST 2017, time=2017-02-09, status=1, ipAttribution=)]
    2017-02-10 Dr.jerry

    每人一百万美元,我的天啊

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2070402, encodeId=415f20e040278, content=<a href='/topic/show?id=f30de0713e1' target=_blank style='color:#2F92EE;'>#疾病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70713, encryptionId=f30de0713e1, topicName=疾病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=010d202, createdName=amy0550, createdTime=Mon Nov 13 02:35:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907466, encodeId=c724190e466c1, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Thu Oct 12 17:35:00 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=176113, encodeId=2cd61e611342, content=榜样的力量, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOWcPEsEP4FrvDcicue5V6rMkmXmY73KjYP59vQrEdjU89iaN4ZkOhsItlHkmGTjhV3b5S3zOQA4E0/0, createdBy=cc261682151, createdName=卡圣, createdTime=Tue Feb 14 12:47:47 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175375, encodeId=9f341e5375be, content=每人一百万美元,我的天啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/30/dd6bade062cb598667f9f577194196c4.jpg, createdBy=422e1687020, createdName=Dr.jerry, createdTime=Fri Feb 10 12:18:02 CST 2017, time=2017-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175241, encodeId=804b1e52415b, content=最有爱的人。, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee471989203, createdName=墨尔, createdTime=Thu Feb 09 23:08:24 CST 2017, time=2017-02-09, status=1, ipAttribution=)]
    2017-02-09 墨尔

    最有爱的人。

    0

相关资讯

32岁的年轻人,向你们致敬!扎克伯格夫妇今日宣布捐赠30亿美元攻克重大疾病

北京时间今日凌晨2点,扎克伯格夫妇宣布,Chan Zuckerberg Initiative将在未来10年内投入30亿美元的巨额资金,资助科学家们攻克世界上最主要的疾病。他们期望在下一代人成长的过程中,能够更少受到疾病的影响,从而过上高质量的生活。扎克伯格夫妇计划在旧金山创立一个生物中心,让科学家们能集中推进项目的进行。这个Initiative的科学委员会成员包括NIH负责人Francis Col

6亿美金砸向生命领域,扎克伯格的细胞FaceBook将怎样改变世界?

斯坦福大学斯蒂芬·奎克的实验室就像托马斯·爱迪生在新泽西州那个大名鼎鼎的工作间的生物版本。窗帘留下的阴影投射到走廊上各种奇怪的,发出嗡鸣声的仪器上。你有一半的可能性可以找到拥有者135项专利的奎克教授,却不大可能碰上穿着褪了色的polo衫、在其中的一个长椅上睡觉的爱迪生。九月份,奎克教授被任命为BioHub的共同总裁。BioHub是facebook的创始人马克·扎克伯格资助6亿美元新建立的研究中心